| Trial ID: | L2490 |
| Source ID: | NCT00993304
|
| Associated Drug: |
Liraglutide
|
| Title: |
A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: liraglutide|DRUG: placebo
|
| Outcome Measures: |
Primary: AUC0-8h (triglyceride), the area under the triglyceride-concentration-time curve in the interval 0-8 hours following a meal with a high fat content, after 3 weeks of treatment | Secondary: FFA (Free Fatty Acid), VLDL (Very Low Density), and apoB48: AUC0-8 hours after meal with a high fat content, after 3 weeks of treatment|Glucose, insulin, C-peptide and glucagon: AUC0-8 hours after meal with a high fat content, after 3 weeks of treatment
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-10
|
| Completion Date: |
2010-12
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-26
|
| Locations: |
Novo Nordisk Investigational Site, Aarhus C, 8000, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00993304
|
